Nearly every colorectal cancer begins as a polyp, a small lump of overgrown lining, and the dangerous ones take about ten to fifteen years to turn. That slow window is why screening works: there's time to cut the polyp out before it's cancer, or catch the cancer while it's curable. Stage I colon cancer has around 91% five-year survival; stage IV, around 14% 1.
A colonoscopy does both jobs — a camera finds the polyps and tools remove them in the same session. The home tests only detect: FIT looks for blood, the stool DNA test adds tumor DNA 2. In the modeling that sets US policy, all three prevent 22 to 25 deaths per 1,000 people screened 3. The gap between tests is small; the gap between any test and none is enormous, against a lifetime risk near one in 25 4.
Pick one, stay on its interval, and treat a positive home result as an appointment, not an answer:
Which test? The one you'll actually finish — on schedule, the three are near-equal 3. Colonoscopy finds and removes in one visit; the cost is a day of bowel prep and a roughly 1-in-1,000 chance of a serious complication 7. FIT is cheapest but yearly, and a positive means a colonoscopy anyway. Cologuard catches more polyps than FIT but flags more false alarms: about 13% get a positive that a scope then clears 2.
The strange part is that most of this payoff is invisible. Screen on schedule and the likeliest outcome is that you never learn the screening did anything: clean results, repeat in a decade, no cancer. The win feels the same as doing nothing. For the 1 in 10 with a polyp found on the first scope, it's removed on the spot and the cancer it would have become never happens. Across the population, the lifetime risk of dying from this cancer falls by about three-quarters 3.
The fine print — when to skip it, and what people get wrong
"The 2022 trial proved colonoscopy fails." No: 58% of those invited never went, and among those who did, deaths fell about 50% 8. "Under 50 means safe." The start age dropped to 45 in 2021 as cancer in the 30s and 40s keeps rising 9.
Colonoscopy carries small real harms: perforation near 1 in 1,000, bleeding after polyp removal near 2 in 1,000 7. A stool test has none, but a positive you never follow up on wastes the whole screen — if it wouldn't get you scoped, pick colonoscopy up front.
- 1Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A (2024). Colorectal cancer statistics, 2024. CA: A Cancer Journal for Clinicians. link
- 2Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. (2014). Multitarget Stool DNA Testing for Colorectal-Cancer Screening. New England Journal of Medicine. link
- 3Knudsen AB, Rutter CM, Peterse EFP, et al. (2021). Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. JAMA. link
- 4National Cancer Institute (2024). SEER Cancer Stat Facts: Colorectal Cancer. link
- 5Patel SG, May FP, Anderson JC, et al. (2022). Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. link
- 6USPSTF (2021). Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. link
- 7Reumkens A, Rondagh EJ, Bakker CM, Winkens B, Masclee AA, Sanduleanu S (2016). Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies. American Journal of Gastroenterology. link
- 8Bretthauer M, Loberg M, Wieszczy P, et al. (2022). Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death. New England Journal of Medicine. link
- 9Wolf AMD, Fontham ETH, Church TR, et al. (2018). Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA: A Cancer Journal for Clinicians. link
დაკავშირებული სახელმძღვანელოში (9)
- — Unexplained iron loss in an adult can mean a slow bleed from the colon. It's a reason to get scoped, not just take iron.
- — Colorectal cancer is one of the cancers this schedule tells you when to screen for.
- — Like cervical screening, this catches the disease at a precancerous stage — the win is in actually going.
- — A clinical panel can flag Lynch syndrome, which means starting colonoscopies young and repeating them far more often than usual.
- — A thinned mucus gel lets bacteria irritate the colon wall — part of why a fibre-poor diet tracks with colon cancer over decades.
- — Rectal bleeding and weight loss overlap with colon-cancer alarm signs, and long-standing IBD itself raises that risk.
- — Colon cancer already has a proven screen; the multi-cancer test mainly adds value for the cancers that have none.
- — In a high-risk trial it halved hereditary cancers years later — but diet is a supplement to colonoscopy, never a replacement.
- — Butyrate is the fuel colon cells run on, and it's a big reason high-fiber eaters get fewer colon cancers — a real edge, but no substitute for screening.
Colorectal Cancer Screening
Microsimulation modeling for USPSTF estimates ~73% lifetime CRC mortality reduction and ~25 CRC deaths averted per 1,000 adults screened from age 45 through 75 (Knudsen 2021). RCT-grade evidence: 25% CRC mortality reduction at 17 years for flex sig (Schoen 2018); per-protocol NordICC 50% mortality reduction with colonoscopy (Bretthauer 2022). One of the few catalogue entries that bends population mortality on a single disease endpoint.
USPSTF A/B-rated screening is covered without cost-sharing under the ACA for in-network providers in average-risk adults 45-75, including diagnostic colonoscopy after a positive stool test (2022 federal rule). Out-of-pocket fallback is non-trivial ($1,500-$5,000 colonoscopy, $500-$700 mt-sDNA, $20-$50 FIT) but for the insured majority it's near-zero.
Multiple RCTs across modalities: Atkin 2010 (UK flex sig, 31% mortality reduction), Schoen 2018 (PLCO 17-year follow-up, 25% mortality reduction), Bretthauer 2022 (NordICC colonoscopy), Imperiale 2014 and 2024 (mt-sDNA validation), plus gFOBT meta-analysis at RR 0.88. USPSTF grade B recommendation (Davidson 2021) backed by Lin 2021 systematic review and Knudsen 2021 microsimulation. Cochrane-tier evidence base.
Stool tests take ~10 minutes once a year (FIT) or every three years (mt-sDNA) and arrive by mail. Colonoscopy requires a day of clear-liquid diet, an unpleasant bowel prep the night before, the procedure with sedation, and a recovery day — but only once a decade. Annualized burden is minor but non-zero.
Trivial felt effect — peace-of-mind benefit after a clean result balanced against false-positive distress (~13% of mt-sDNA users in a given year, Imperiale 2014) and procedure anxiety. Not a meaningful mood intervention on either side.